Profund Advisors’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$277K Buy
47,594
+28,641
+151% +$190K 0.01% 860
2026
Q1
$137K Buy
18,953
+4,368
+30% +$56.9K 0.01% 1058
2025
Q4
$248K Sell
14,585
-10,137
-41% -$103K 0.01% 1016
2025
Q3
$181K Buy
24,722
+2,215
+10% +$17.9K 0.01% 999
2025
Q2
$146K Sell
22,507
-10,738
-32% -$70.9K 0.01% 943
2025
Q1
$337K Buy
33,245
+17,234
+108% +$188K 0.01% 622
2024
Q4
$198K Buy
16,011
+4,107
+35% +$54.8K 0.01% 1015
2024
Q3
$97.6K Buy
11,904
+1,279
+12% +$7.64K ﹤0.01% 1113
2024
Q2
$53K Buy
+10,625
New +$60.6K ﹤0.01% 1067
2018
Q4
Sell
-4,896
Closed -$245K 1443
2018
Q3
$245K Buy
+4,896
New +$221K 0.01% 1335

Other funds holding WVE

Profund Advisors's WVE Position: Q2 2026 in Review

Profund Advisors increased its Wave Life Sciences (WVE) stake by 151% in Q2 2026, buying an estimated $190K and bringing the position to 47,594 shares worth $277K. The position accounts for 0.01% of the portfolio, ranked #860.

Profund Advisors first reported a position in WVE in Q3 2018 and has held it in 10 quarters since. The position peaked at $337K in Q1 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Profund Advisors held 47,594 shares of Wave Life Sciences worth $277K as of Q2 2026.
  • Profund Advisors bought 28,641 Wave Life Sciences shares in Q2 2026, an estimated $190K.
  • Wave Life Sciences made up 0.01% of Profund Advisors's portfolio in Q2 2026, its #860 holding.
  • Profund Advisors first reported a position in Wave Life Sciences in Q3 2018 and has held it in 10 quarters since.
  • Profund Advisors's Wave Life Sciences position peaked at $337K in Q1 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.